Edition:
India

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

803.40INR
9:36am IST
Change (% chg)

Rs5.40 (+0.68%)
Prev Close
Rs798.00
Open
Rs803.00
Day's High
Rs804.95
Day's Low
Rs800.00
Volume
20,503
Avg. Vol
538,878
52-wk High
Rs1,274.70
52-wk Low
Rs752.30

Select another date:

Thu, Dec 28 2017

BRIEF-Sequent Scientific Gets Shareholders' Nod For Scheme Of Arrangement with Strides Shasun

* GETS SHAREHOLDERS' NOD TO APPROVE SCHEME OF ARRANGEMENT BETWEEN STRIDES SHASUN, CO AND SOLARA ACTIVE PHARMA SCIENCES Source text: (http://bit.ly/2DoTPO4) Further company coverage:

BRIEF-Strides Shasun Gets Shareholders' Nod For Composite Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences

* GETS SHAREHOLDERS' NOD FOR COMPOSITE SCHEME OF ARRANGEMENT BETWEEN CO, SEQUENT SCIENTIFIC AND SOLARA ACTIVE PHARMA SCIENCES Source text - http://bit.ly/2pNrrDh Further company coverage:

BRIEF-Strides Shasun Acquires Controlling Stake In Trinity Pharma

* SAYS ACQUIRES CONTROLLING STAKE IN TRINITY PHARMA, SOUTH AFRICA

BRIEF-Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed

* SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED Source text - http://bit.ly/2kkCPEo Further company coverage:

BRIEF-Strides Shasun gets U.S. FDA approval for acetazolamide tablets​

* Says product to be marketed by Strides Pharma Inc in the US market‍​ Source text for Eikon: Further company coverage:

BUZZ-Strides, Eris rise on deal for India brand business

** Strides Shasun Ltd rises as much as 4.5 pct to its highest in almost a fortnight

BRIEF-Strides Shasun approves scheme of amalgamation for merger of units with co‍​

* Says approved scheme of amalgamation for merger of units Arrow Remedies, Fagris Medica, Strides Chemicals with co‍​ Source text - http://bit.ly/2A2odNz Further company coverage:

BRIEF-India's Strides Shasun Sept-qtr consol profit down 87 pct

* Sept quarter consol net profit 107.3 million rupees versus profit of 854.3 million rupees last year

BRIEF-Strides Shasun gets U.S. FDA approval for omega-3-acid ethyl esters capsules

* Says Strides Shasun receives USFDA approval for omega-3-acid ethyl esters capsules

BRIEF-Strides Shasun gets shareholders' nod for appointment of Shashank Sinha as MD

* Gets shareholders' nod for appointment of Shashank Sinha as MD Source text: http://bit.ly/2x75CQP Further company coverage:

Select another date: